Navigation Links
Bud Owen and Tony Click Join Clinverse, Inc. as Chief Financial Officer and Chief Technology Officer
Date:7/31/2013

Raleigh, NC (PRWEB) July 31, 2013

Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today the addition of Bud Owen as Chief Financial Officer and Tony Click as Chief Technology Officer. Both Bud and Tony bring extensive experience in their respective fields and serve as strategic members of the management team for the company.

In his role as CFO, Bud leads all financial aspects of the company, including accounting, treasury, tax and human resources activities. He is a veteran senior finance executive who was most recently with Clinipace, Inc., a global CRO. Prior to Clinipace, Bud served as CFO at a number of global companies in the software, web services, media and chemical industries. During his career, he has been either a principal or an advisor in more than 40 M&A transactions with a total transaction value of $1.5 billion. Bud has a Master of Business Administration from Queens University (Canada) and is an Ernst & Young (Toronto) alumni.

As Chief Technology Officer, Tony is responsible for all technical and architectural aspects of Clinverse’s software and eclinical commerce network. He brings more than 20 years of experience developing customer software solutions across many industries including finance, insurance, publishing, telecom, construction and utilities. His specialties include systems with high throughput, computationally intensive and ‘Big Data’ requirements. Prior to joining Clinverse, Tony provided outsourced CTO services for early-stage startups and served as the VP of Enterprise Architecture at Merkle, a database analytics company. Tony also ran his own consulting firm for 11 years, which delivered architectural and project management services. He received a Bachelor of Science in Electrical Engineering from Virginia Tech and a Master of Business Administration from Duke University’s Fuqua School of Business.

"We look forward to leveraging Bud and Tony’s industry knowledge and expertise to continue to grow our lead in the area of financial lifecycle systems for the clinical trials industry," said Steve Ayala, Clinverse co-founder and president. "Their leadership and experience are critical to our success as we continue to expand globally and seek to provide our customers with exceptional financial process automation solutions that fill an important, yet unmet need in clinical trials."

About Clinverse, Inc.

Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay®, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit http://www.clinverse.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10973719.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
2. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
3. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
4. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
5. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
6. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
7. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
8. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
9. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
10. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
11. Codexis Names Wes Bolsen VP and Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... ... its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the use ... , PathSensors deploys the CANARY® test platform for the detection of harmful pathogens, ...
(Date:4/27/2016)... ... 2016 , ... Global Stem Cells Group and the University of ... research and development initiatives for potential stem cell protocol management for 2016 – 2020. ... executives began meeting to establish a working agenda and foster initiatives to promote stem ...
(Date:4/26/2016)... ... April 27, 2016 , ... Cameron ... LLP as an associate in the firm’s Intellectual Property practice group. , Clients ... electromechanical patent applications. He has an electrical engineering and computer engineering background, and ...
(Date:4/26/2016)... ... April 26, 2016 , ... ... announces the latest technology innovation for its Volume Pattern Generator (VPG) line of ... production of advanced photomasks as well as a solution for mid volume direct ...
Breaking Biology Technology:
(Date:3/10/2016)... --  Unisys Corporation (NYSE: UIS ) today announced ... testing its biometric identity solution at the Otay Mesa border ... identify certain non-U.S. citizens leaving the country. ... determine the efficiency and accuracy of using biometric technologies in ... until May 2016. --> the United States ...
(Date:3/9/2016)... Nigeria . Recently, ... 23,000 public service employees either did not exist with ... unlawfully.    --> Nigeria . ... than 23,000 public service employees either did not exist ... salary unlawfully.    --> DERMALOG, the biometrics ...
(Date:3/8/2016)... March 8, 2016   Valencell , the ... announced it has secured $11M in Series D ... a new venture fund being launched by UAE-based ... from existing investors TDF Ventures and WSJ Joshua ... continue its triple-digit growth and accelerate its pioneering ...
Breaking Biology News(10 mins):